Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-041485

Options or other derivatives

  • Oxtoby Andrew acquired 476,611 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Oxtoby Andrew

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-18 Grant or award : show line 1 in the form Stock Option (right to buy) +476,611 476,611 D
Loading xslF345X05/ownership.xml…